How much funding has Phathom Pharmaceuticals raised?

Phathom Pharmaceuticals has raised $450.3M in total funding, most recently a Venture Round.

Who are Phathom Pharmaceuticals's investors?

Phathom Pharmaceuticals's investors include SVB Capital, New Enterprise Associates.

When was Phathom Pharmaceuticals founded?

Phathom Pharmaceuticals was founded in 2018.

Where is Phathom Pharmaceuticals headquartered?

Phathom Pharmaceuticals is headquartered in Florham Park, New Jersey, United States.

What industry is Phathom Pharmaceuticals in?

Phathom Pharmaceuticals operates in Biotech, GI Health, Healthcare, Therapeutics.

How many employees does Phathom Pharmaceuticals have?

Phathom Pharmaceuticals has 201-500 employees.

Phathom Pharmaceuticals

IPO

Leading the way to innovative treatments for gastrointestinal diseases

Public · Florham Park, United States · Founded 2018 · $450.3M raised

Biotech

GI Health

Healthcare

Therapeutics

Headquarters: Florham Park, New Jersey
Employees: 201–500
Founded: 2018
Business Model: B2B
Website: phathompharma.com

Total Funding: $450.3M
Last Round: $150.3M Venture RoundMay 2023
Rounds: 3
Type: Public

About

Phathom Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing new treatments for acid-related gastrointestinal disorders. The company holds exclusive US, European, and Canadian rights to a potassium-competitive acid blocker (PCAB), a next-generation mechanism that offers an alternative to proton pump inhibitors for conditions such as erosive esophagitis and H. pylori infection.

Summary

Phathom Pharmaceuticals is a Biotech company based in Florham Park, United States, founded in 2018. It has raised $450.3M in total across 3 rounds, most recently a $150.3M Venture Round round in May 2023. Investors include SVB Capital and New Enterprise Associates.

LinkedIn X (Twitter)